The Folly of ‘America First’ in the Race for Biodata Amid a Pandemic
By Tamsin Shaw,
The New York Review of Books
| 05. 13. 2020
Genomic biodata is essential for epidemiology, as well as for the development of vaccines and treatments. America’s response to the coronavirus pandemic has exposed its shocking lack of preparedness for a public health emergency.
America’s response to the coronavirus pandemic has exposed a shocking lack of preparedness for public health emergencies. But it has also revealed what must be, for the aspiring strongman in the White House and his coterie, a more embarrassing fact: if America were to move in an authoritarian direction, it would be shedding international allies in order to enter into a competition with nationalistic authoritarian states that it probably can’t win.
The strengths that the US has built over the seventy-five years since World War II lie elsewhere—and they are ones that the Trump administration clearly doesn’t recognize. If the White House had chosen the standard liberal-democratic approach to a pandemic for which we were once well prepared, it would have prioritized public health goals: minimizing suffering and reducing mortality rates, and thereby also mitigating the damage to social, economic, and political institutions. That approach would have meant global cooperation, scientific collaboration, and humanitarian aid to poorer countries to help halt the spread of the virus.
But this administration did not choose that path. The president is a fan neither...
Related Articles
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...
By Maoli Duan, The Conversation | 07.02.2025
By Alice Park, TIME | 07.08.2025
Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth.
To date, there haven’t been many reliable treatment options for these babies. The few that do exist involve...
By Jessica Hamzelou, MIT Technology Review | 07.18.2025
This week we heard that eight babies have been born in the UK following an experimental form of IVF that involves DNA from three people. The approach was used to prevent women with genetic mutations from passing mitochondrial diseases to...